INMED PHARMACEUTICALS INC (INM) Stock News
NASDAQ:INM - Nasdaq - CA4576377002 - Common Stock
INM Latest News and Analysis
Get insights into the top gainers and losers of Tuesday's after-hours session.
Get insights into the top gainers and losers of Tuesday's after-hours session.
Nano-Cap InMed Ignites Retail Frenzy As Stock Soars After Alzheimer's Drug Trial Shows Promise
The positive trial results propelled InMed into the top 25 trending stocks on Stocktwits, with a flood of bullish comments on the platform.
Why InMed Pharmaceuticals (INM) Stock Is Skyrocketing
InMed Pharmaceuticals shares are trading higher by 45% during Tuesday's session. The company announced that INM-901 reduced Alzheimer 's-related inflammation in a preclinical study.
Which stocks are moving before the opening bell on Tuesday?
Stay updated with the stocks that are on the move in Tuesday's pre-market session.
InMed Pharmaceuticals Demonstrates INM-901 as an Oral Formulation Targeting Alzheimer’s Disease
August 20, 2024 7:30 AM EDT | Source: InMed Pharmaceuticals High bioavailability of INM-901 oral formulation provides similar drug concentration levels in the brain as intraperitoneal (IP) injection Vancouver, British Columbia–(Newsfile Corp. – August 20, 2024) – InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company”), a pharmaceutical company focused on developing a pipeline of […]
InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on “Minor Cannabinoids”
InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration
7 F-Rated Growth Stocks to Avoid Right Now: June 2024
A good rating for growth in the Portfolio Grader doesn't tell the full picture. These are all growth stocks to avoid now.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news affecting shares this morning!
INM Stock Earnings: InMed Pharmaceuticals Reported Results for Q3 2024
InMed Pharmaceuticals just reported results for the third quarter of 2024.
INM Stock Earnings: InMed Pharmaceuticals Reported Results for Q3 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips InMed Pharmaceuticals (NASDAQ:INM) just reported results for the third quarter ...
InMed Pharmaceuticals announces appointment of Netta Jagpal as CFO (NASDAQ:INM)
InMed Pharmaceuticals (INM) Friday announced the appointment of Netta Jagpal as Chief Financial Officer and Corporate Secretary, effective February 20. Jagpal j
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Business Update, Milestones
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!
InMed Pharmaceuticals files to sell 12.57M shares for holders (NASDAQ:INM)
InMed Pharmaceuticals files prospectus for resale of 12.57M shares by selling shareholders, not an offer to sell securities.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we're starting the morning with a breakdown of the biggest ones.
EVGO Stock Slips as TD Cowen Downgrades EVgo
EVgo stock is taking a beating on Wednesday as investors in the EV charging company deal with a downgrade and price cut.
Why Is BioXcel Therapeutics (BTAI) Stock Up 42% Today?
BioXcel Therapeutics stock is rising on Wednesday as investors in BTAI stock react to results from an audit on a clinical trial.